| 英文名称 | 中文名称 | CAS | MF |
|
Nat 02-677
|
|
54996-53-1
|
C8H7NOSe
|
|
Nasicon
|
|
|
|
|
NARROWLEAVEDLUPINSEEDS
|
|
|
|
|
nasimalun B
|
|
|
|
|
nasimalun A
|
|
|
|
|
NBI 35965 hydrochloride
|
NBI 35965 hydrochloride
|
603151-83-3
|
C22H26Cl2N4O3S
|
|
N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide
|
N-[3-[(4AR,5S,8R,8AS)-1-[(4-氟苯基)甲基]-1,2,4A,5,6,7,8,8A-八氢-4-羟基-2-氧代-5,8-甲桥喹啉-3-基]-1,1-二氧代-2H-1,2,4-苯并噻二嗪-7-基]甲磺酰胺
|
1071517-39-9
|
C25H25FN4O6S2
|
|
NARTHANGAIPICKLE
|
|
|
|
|
Nartograstim
|
那托司亭
|
|
|
|
Nartograstim
|
|
134088-74-7
|
|
|
NarT protein
|
|
|
|
|
natalizuMab
|
那他珠单抗
|
|
|
|
Natalenone
|
|
60548-82-5
|
C22H16O6
|
|
Nataloe-emodin 8-methyl ether
|
NATALOE-EMODIN 8-METHYL ETHER
|
125708-14-7
|
C16H12O5
|
|
Natamycinolide
|
|
60395-07-5
|
C27H36O10
|
|
NatamycinUsp28
|
|
|
|
|
NARUMICIN I
|
|
136005-76-0
|
C37H66O7
|
|
Natamycin50%Lactose
|
|
|
|
|
NARUMICIN I
|
|
|
C37H66O7
|
|
Natamycin
|
纳他霉素
|
7681-93-8
|
C33H47NO13
|
|
Natamycin(Pimaricin)
|
|
|
|
|
Natamycin50%Glucose
|
|
|
|
|
Natamycin50%XanthanGum
|
|
|
|
|
Narvel
|
|
|
|
|
Na(+)-taurocholate-cotransporting peptide
|
|
|
|
|
(+/-)-Narwedine
|
(+/-)-那维定
|
1668-86-6
|
C17H19NO3
|
|
Elagolix Sodium
|
恶拉戈利钠
|
832720-36-2
|
C32H29F5N3NaO5
|
|
NAT--D-glucuronide
|
|
|
C16H19N3O7
|
|
Na2SO3
|
|
|
Na2S2O3
|
|
N-β-Hydroxyethyl coco imidazoline
|
N-B-HYDROXYETHYL COCO IMIDAZOLINE
|
|
|
|
N-β-Hydroxyethyl oleyl imidazoline
|
4,5-二氢化-2-(8-十七碳烯基)-1H-咪唑-1-乙醇
|
95-38-5
|
C22H42N2O
|
|
N-β-Hydroxyethyl oleyl imidazoline
|
|
|
C23H44N2O
|
|
N-(β-Hydroxyethyl)-1-naphthylamine
|
|
|
C12H13NO
|
|
N-(b-Hydroxytrimethylen)morpholinium chloride
|
|
52900-07-9
|
C7H14NO2.Cl
|
|
N-β-Hydroxyethyl stearyl imidazoline
|
|
|
C23H46N2O
|
|
NARX protein
|
|
|
|
|
Nateglinide Acyl--D-glucuronide
|
Nateglinide Acyl--D-glucuronide
|
183996-85-2
|
C25H35NO9
|
|
Nateglinide Acyl-β-D-glucuronide Benzyl Ester
|
Nateglinide Acyl-β-D-glucuronide Benzyl Ester
|
|
C32H41NO9
|
|
Nateglinide-d5 Ethyl Ester
|
|
|
C21H31NO3
|
|
Nateglinide Ethyl Ester
|
那格列奈乙酯
|
187728-85-4
|
C21H31NO3
|
|
NateglinideOralAntidiabetics&RelatedDrugs
|
|
|
|
|
Nateglinide
|
那格列奈
|
105816-04-4
|
C19H27NO3
|
|
Nateglinide-d5
|
那格列奈-D5
|
1227666-13-8
|
C19H22D5NO3
|
|
nateglinide
|
那格列奈杂质3
|
491828-09-2
|
C19H27NO3
|
|
Nateglinide
|
|
|
|
|
Nateglinide,HypoglycemicAgent
|
|
|
|
|
nasohypophysial factor
|
|
|
|
|
NASON
|
|
|
|
|
Nateplase
|
那替普酶
|
159445-63-3
|
|
|
NASOPHARYNGEALCANCER
|
|
|
|
|
nasopharyngeal carcinoma ELISA diagnostic kit
|
鼻咽癌酶免疫诊断试剂盒
|
|
|
|
N-(4-biphenyl)-(9,9-dimethylfluoren-2--yl)Amine
|
N-[1,1'-联苯-4-基]-9,9-二甲基-9H-芴-2-胺
|
897671-69-1
|
C27H23N
|
|
N-(biphenyl-2-yl)-2-chloro-N-methylacetamide
|
N-(biphenyl-2-yl)-2-chloro-N-methylacetamide
|
955879-95-5
|
C15H14ClNO
|
|
N-[1,1'-Biphenyl]-2-yl-9,9-dimethyl-9H-fluoren-2-amine
|
N-[1,1'-联苯]-2-基-9,9-二甲基-9H-芴-2-胺
|
1198395-24-2
|
C27H23N
|
|
N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl-2-pyrrolidinedicarboxamide
|
TCS 1102
|
916141-36-1
|
C27H26N4O2S
|
|
N-[1,1'-Biphenyl]-4-yl-9,9-diphenyl-9H-fluoren-2-amine
|
联苯-4-基(9,9-二苯基芴-2-基)胺
|
1268520-04-2
|
C37H27N
|
|
N-Biphenyl-2-yl-N'-(4,6-dimethylpyrimidin-2-yl)-guanidine
|
N-联苯-2-基-N'-(4,6-二甲基嘧啶-2-基)胍
|
356082-07-0
|
C19H19N5
|
|
N-[1,1'-biphenyl]-4-yl-N-(4-broMophenyl)-9,9-diMethyl-9H-Fluoren-2-aMine
|
N-[1,1`-联苯]-4-基-N-(4-溴苯肼)-9,9-二甲基-9H-芴-2-胺
|
1246562-40-2
|
C33H26BrN
|
|
N-[1,1'-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine
|
N-[1,1'-联苯]-4-基-9,9-二甲基-9H-芴-3-胺
|
1326137-97-6
|
C27H23N
|
|
N-(biphenyl-2-yl)-3-(N-(2,5-diMethylphenyl)sulfaMoyl)-4-MethylbenzaMide
|
N-(biphenyl-2-yl)-3-(N-(2,5-diMethylphenyl)sulfaMoyl)-4-MethylbenzaMide
|
824981-55-7
|
C28H26N2O3S
|
|
N-(biphenyl-4-yl)pent-4-enaMide
|
N-([1,1'-联苯] -4-基)戊-4-烯酰胺
|
1385768-77-3
|
C17H17NO
|
|
N-(4-biphenyl)carbazole-2-boronic acid pinacol ester
|
N-(4-联苯基)咔唑-2-硼酸频哪醇酯
|
|
|
|
N-(biphenyl-4-yl)-1H-indole-3-carboxaMide
|
N-(联苯-4-基)-1H-吲哚-3-甲酰胺
|
|
C21H16N2O
|
|
N-(biphenyl-4-yl)-N-(4-broMophenyl)biphenyl-4-aMine
|
N-(4-溴苯基)-N,N-二-(4-联苯基)胺
|
|
C30H22BrN
|
|
N-(biphenyl-4-yl)Naphthalene-2-aMine
|
N-(4-联苯基)-2-萘胺
|
6336-92-1
|
C22H17N
|
|
N-Biphenyl-2-yl-forMaMide
|
2'-PHENYLFORMANILIDE
|
5346-21-4
|
C13H11NO
|
|
N-[1,1'-biphenyl]-4-yl-2-(phenylsulfonyl)acetamide
|
|
|
C20H17NO3S
|
|
N-[1,1'-biphenyl]-3-yl-3-methoxybenzamide
|
|
|
C20H17NO2
|
|
N-[1,1'-biphenyl]-2-yl-2-[[(4-methylphenyl)sulfonyl]-3-(trifluoromethyl)anilino]acetamide
|
|
664313-69-3
|
C28H23F3N2O3S
|
|
N-[1,1'-biphenyl]-2-yl-6-methyl-2-phenyl-4-quinolinecarboxamide
|
|
337504-13-9
|
C29H22N2O
|
|
N-[1,1'-biphenyl]-2-yl-3-chloro-6-methyl-1-benzothiophene-2-carboxamide
|
|
332381-25-6
|
C22H16ClNOS
|
|
N-[1,1'-biphenyl]-4-ylbenzo[cd]indol-2-amine
|
|
370587-08-9
|
C23H16N2
|
|
N-(3-{4-[([1,1'-biphenyl]-4-ylcarbonyl)amino]benzyl}phenyl)[1,1'-biphenyl]-4-carboxamide
|
|
499189-17-2
|
C39H30N2O2
|
|
N-(4-Biphenylyl)diacetamide
|
|
|
C16H15NO2
|
|
N-Biphenyl-2-yl-3,4-dihydropyrazino[1,2-a]indole-2(1H)-carboxamide
|
|
|
C24H21N3O
|
|
N-Biphenyl-2-yl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxamide
|
|
|
C26H26N4O2
|
|
N'-Biphenyl-2-yl-N-[1-(3-cyanobenzyl)piperidin-4-yl]-N-(pyridin-3-ylmethyl)urea
|
|
|
C32H31N5O
|
|
N-(1,1'-Biphenyl)-4-yl-N-(sulfooxy)acetamide monopotassium salt
|
|
71799-99-0
|
|
|
N-(4-[1,1'-biphenyl]-4-yl-5-methyl-1,3-thiazol-2-yl)-4-bromobenzamide
|
|
313230-19-2
|
C23H17BrN2OS
|
|
N'-Biphenyl-2-yl-N-[1-(3-cyanobenzyl)piperidin-4-yl]-N-(2-furylmethyl)urea
|
|
|
C31H30N4O2
|
|
N-(Biphenyl-2-yl)-2-(4-((4-chlorophenylthio)methyl)-6-hydroxypyrimidin-2-ylthio)acetamide
|
|
|
C25H20ClN3O2S2
|
|
N,4-Biphenyl-N-hydroxy-D-glucuronosylamine
|
|
67068-87-5
|
C18H20NNaO7
|
|
N-(4-Biphenyl-4-yl-thiazol-2-yl)-2-chloro-acetamide
|
2-氯-N-[4-(4-苯基苯基)-1,3-噻唑-2-基]乙酰胺
|
726153-55-5
|
C17H13ClN2OS
|
|
N2-[(1-[1,1'-biphenyl]-4-yl-1-methylethoxy)carbonyl]-L-glutamine
|
|
25692-86-8
|
C21H24N2O5
|
|
N-[1,1'-biphenyl]-2-yl-2,3-dihydro-1,4-benzodioxine-6-sulfonamide
|
|
|
C20H17NO4S
|
|
N'-([1,1'-biphenyl]-4-ylmethylene)-2-bromobenzohydrazide
|
|
331271-27-3
|
C20H15BrN2O
|
|
N-4-Biphenylylbenzenesulfonamide
|
|
13607-48-2
|
C18H15NO2S
|
|
4-[N'-(Biphenyl-4-carbonyl)-hydrazino]-4-oxo-butyric acid
|
|
|
C17H16N2O4
|
|
N-(2-[1,1'-biphenyl]-4-yl-2,7a-dihydro-1,3-benzoxazol-5-yl)-3-methyl-1-benzofuran-2-carboxamide
|
|
|
C29H22N2O3
|
|
N-([1,1'-biphenyl]-4-ylcarbonyl)-N'-{4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl}thiourea
|
|
|
C25H26N4O3S2
|
|
N-{1-[([1,1'-biphenyl]-4-ylamino)carbonyl]-2-methylpropyl}-2-[(4-methoxybenzoyl)amino]benzamide
|
|
|
C32H31N3O4
|
|
N'-([1,1'-biphenyl]-4-ylcarbonyl)-N-methyl-N-phenylthiourea
|
|
712318-89-3
|
C21H18N2OS
|
|
N-(4-Biphenylyl)benzamide
|
|
|
C19H15NO
|
|
N-([1,1'-Biphenyl]-4-ylmethyl)-4-(isopentyloxy)-aniline
|
N-([1,1'-BIPHENYL]-4-YLMETHYL)-4-(ISOPENTYLOXY)-ANILINE
|
1040688-78-5
|
C24H27NO
|
|
N'-[1-(1,1'-biphenyl-4-yl)ethyl]-N,N-dimethylethane-1,2-diamine
|
|
|
C18H24N2
|
|
N-[1-(1,1'-biphenyl-4-yl)ethyl]-N-(2-furylmethyl)amine
|
|
|
C19H19NO
|
|
N-[1-(1,1'-biphenyl-4-yl)ethyl]-N-methylamine
|
|
|
C15H17N
|
|
N-[1-(1,1'-biphenyl-4-yl)ethyl]-N-cyclopropylamine
|
|
|
C17H19N
|
|
N'-(1,1'-biphenyl-4-ylmethyl)-N,N-dimethylethane-1,2-diamine
|
|
|
C17H22N2
|
|
N-[1,1'-biphenyl]-2-yl-2,2'-biphthalimide-5-carboxamide
|
|
|
C29H19N3O5
|